>50%
Research sites enroll 0 or 1 patient per study
A proven partner for faster, high-quality clinical trials
Iterative Health empowers GI and hepatology research sites worldwide with specialized operations, staffing, and technology, enabling centralized access to high-performing sites, diverse patient populations, and faster, more predictable trials.
Challenges we solve for
Clinical development is more complex, expensive, and hard to execute, as sponsors and CROs struggle with site selection, slow startup, enrollment gaps, and data issues that raise regulatory risk.
Accelerate trial success with the leading,
performance-driven Site Network
We partner with biopharma and CROs to accelerate GI and hepatology
trials while reducing risk and protecting data quality.
trials while reducing risk and protecting data quality.
Our promise to
sponsors and CROs
We promise sponsors and CROs faster, more confident site selection, industry-leading enrollment volume per site, and reduced operational burden. With clear visibility into performance and progress, we provide a consistent, reliable partnership across every study and program.
Powering a network that delivers
We help investigators and sponsors run clinical trials more efficiently,
accelerating enrollment, reducing operational burden, and
delivering reliable results at scale.
accelerating enrollment, reducing operational burden, and
delivering reliable results at scale.
0+
Research
sites
sites
0M
Patient
reach
reach
0+
Sponsor & CROrelationships
0
IBD patient randomized
on average every day
on average every day
Accelerating timelines by months
without compromising quality
Get life-changing therapies to patients faster with a site network that delivers rapid
startup, first patient in, and industry-leading enrollment and retention
startup, first patient in, and industry-leading enrollment and retention
Therapeutic focus areas
We focus on select therapeutic areas to deliver
deeper expertise and better clinical trial outcomes.
Gastrointestinal
IBD, IBS-C/D/M/U, EoE, Celiac, GERD, C.Diff, Barrett’s Esophagus, Gastroparesis, Oncology, and more
Hepatology
MASLD/MASH,
PBC, PSC, ALD, MAFLD,
AutoImmune Hepatitis (AIH)
Obesity
Weight loss, studies of GLP1s and GIPs in comorbid conditions, and treatment of associated GI AEs
Capabilities at a glance
Trial Phases: 1b to 4
Study types supported:
Study types supported:
Site enablement reimagined
for trial acceleration
Iterative Health doesn’t monitor sites - we empower high-performing, sustainable research sites. Our innovative partnership model enables top-notch study performance that aligns to sponsors' needs:
Confident site selection
Site performance and capabilities data accelerates feasibility and informs confident site selection
Streamlined contracting
Centralized processes reduce friction, accelerate budget alignment, and cut down contracting timelines
Accelerated study start-up
Dedicated operational support for regulatory submissions, protocol-specific training, ancillary contracting, and other requirements cuts study activation time in half
Regulatory and quality expertise
A centralized team of domain experts drive compliance, audit readiness, and exceptional data quality
AI-powered patient recruitment
Proprietary AI-powered technology enables research specialists to quickly pre-screen eligible patients, saving hours of manual chart review and driving industry-leading randomization rates
Specialized training and development
Central clinical operations teams provide site staff with protocol-specific training and resources to ensure understanding, adherence, and advance performance
Integrated study maintenance and closeout support
Sites receive continuous operational partnership across the trial lifecycle, with weekly check-ins and on-demand support. Sponsors and CROs receive clear visibility and meaningful progress updates
Improved site communication
Dedicated teams support PI and Clinical Research Coordinator (CRC) engagement and communication, powering research motivation and enabling swift resolution that keeps trials on track
Explore our AI-powered
research collaborations
Iterative Health partners with leading biopharma companies and world-renown academic researchers to explore how advanced AI technology can advance precision IBD care by improving clinical trial methodologies and endoscopic assessments.
Resources and insights in clinical research
Learn from experts, case studies, and best practices that are driving faster, more efficient,
and patient-focused clinical trials in GI, hepatology, and beyond
and patient-focused clinical trials in GI, hepatology, and beyond
A Closer Look at Dr. DuVall’s Clinical Leader Article on Accelerating Clinical Trials
Dr. DuVall explains how community-based research sites speed study activation, expand patient access, and improve trial execution by embedding research into everyday care.
Learn More
Building Sustainable Clinical Research Sites, Why the Future of Clinical Trials Depends on It: Interview with Dana Feuchtbaum
Dana outlines why sustainable clinical research sites are essential to the future of trials and how strategic investment strengthens sites and improves patient access.
Learn More
Case Study: How Gastro One Accelerated a Complex Phase 1b-A GI Trial with Iterative Health
This case study shows how Iterative Health helped Gastro One accelerate a complex Phase 1b-A GI trial through streamlined operations and improved patient retention.
Learn More
Let's partner
Whether you’re a sponsor, CRO, or biotech company planning a clinical trial or interested in a research collaboration, we’re here to support your goals with data-driven insights and operational expertise. Get in touch to discuss partnership opportunities, request an enrollment forecast, and explore how Iterative Health can help.
Get in touch